General MedicationsOPHTHALMICGeneric
MYDCOMBI
PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
Standard Dose
2.5%;1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MYDCOMBI is listed in Drugs@FDA under application 215352 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE Form and strength SPRAY, METERED;OPHTHALMIC - 2.5%;1% Sponsor EYENOVIA Submission history Latest submission status date: 2023-05-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview MYDCOMBI is listed in Drugs@FDA under application 215352 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE Form and strength SPRAY, METERED;OPHTHALMIC - 2.5%;1% Sponsor EYENOVIA Submission history Latest submission status date: 2023-05-05 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.